New perspectives on techniques for the clinical psychiatrist: Brain stimulation, chronobiology and psychiatric brain imaging

Psychiatry and Clinical Neurosciences

Volumn 62, Issue 6, 2008, Pages 627-637

  Zanardi, Raffaella ^a   Barbini, Barbara ^a   Rossini, David ^a   Bernasconi, Alessandro ^a   Fregni, Felipe ^b   Padberg, Frank ^c   Rossi, Simone ^d   Wirz Justice, Anna ^e   Terman, Michael ^f   Martiny, Klaus ^g   Bersani, Giuseppe ^h   Hariri, Ahmad R ⁱ   Pezawas, Lukas ^j   Roiser, Jonathan P ^k   Bertolino, Alessandro ^l   Calabrese, Giovanna ^m   Magri, Lorenzo ^a   Benedetti, Francesco ^a   Pontiggia, Adriana ^a   Malaguti, Alessia ^a   Smeraldi, Enrico ^a   Colombo, Cristina ^a   more..

^a SAN RAFFAELE HOSPITAL   (Italy)

^b HARVARD MEDICAL SCHOOL   (United States)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY OF SIENA   (Italy)

^e UNIVERSITY OF BASEL   (Switzerland)

^f Department of Medicine   (United States)

^g FREDERIKSBORG GENERAL HOSPITAL   (Denmark)

^h SAPIENZA UNIVERSITY OF ROME   (Italy)

ⁱ UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^j MEDICAL UNIVERSITY OF VIENNA   (Austria)

^k UNIVERSITY COLLEGE LONDON   (United Kingdom)

^l UNIVERSITY OF BARI   (Italy)

^m RHO HOSPITAL   (Italy)

more..

Author keywords

Chronobiology; Depression; Neuroimaging; Transcranial magnetic stimulation

Indexed keywords

FLUOXETINE; LITHIUM SALT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

BRAIN DEPTH STIMULATION; CHRONOBIOLOGY; CHRONOTHERAPY; CLINICAL DECISION MAKING; CLINICAL TRIAL; COGNITIVE THERAPY; DEPRESSION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GILLES DE LA TOURETTE SYNDROME; HUMAN; MAJOR DEPRESSION; MOOD DISORDER; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBSESSIVE COMPULSIVE DISORDER; PHOTOTHERAPY; POSITRON EMISSION TOMOGRAPHY; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHIATRIC TREATMENT; PSYCHIATRIST; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SLEEP DEPRIVATION; TRANSCRANIAL MAGNETIC STIMULATION;

BRAIN; DIAGNOSTIC IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MENTAL DISORDERS; MOOD DISORDERS; PERIODICITY; PSYCHIATRY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 56849109835     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2008.01863.x     Document Type: Review

References (88)

1. Kruijshaar ME, Barendregt J, Vos T, de Graaf R, Spijker J, Andrews G. Lifetime prevalence estimates of major depression: An indirect estimation method and a quantification of recall bias. Eur. J. Epidemiol. 2005 20 : 103 111.
2. Hallett M. Transcranial magnetic stimulation and the human brain. Nature 2000 406 : 147 150.
3. Hallett M. Transcranial magnetic stimulation: A primer. Neuron 2007 55 : 187 199.
4. Walsh V, Cowey A. Transcranial magnetic stimulation and cognitive neuroscience. Nat. Rev. Neurosci. 2001 1 : 73 79.
5. Rossi S, Rossini PM. TMS in cognitive plasticity and the potential for rehabilitation. Trends Cogn. Sci. 2004 8 : 273 279.
6. Padberg F, Möller HJ. Repetitive transcranial magnetic stimulation: Does it have potential in the treatment of depression? CNS Drugs 2003 17 : 383 403.
7. Keck ME. rTMS as treatment strategy in psychiatric disorders: Neurobiological concepts. Suppl. Clin. Neurophysiol. 2003 56 : 100 116.
8. Pogarell O, Koch W, Pöpperl G et al. Dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: Preliminary results of a dynamic [123I] IBZM SPECT study. J. Psychiatr. Res. 2006 40 : 307 314.
9. Strafella AP, Ko JH, Grant J, Fraraccio M, Monchi O. Corticostriatal functional interactions in Parkinson's disease: A rTMS/[11C]raclopride PET study. Eur. J. Neurosci. 2005 22 : 2946 2952.
10. Khedr EM, Rothwell JC, Shawky OA, Ahmed MA, Foly KN, Hamdy A. Dopamine levels after transcranial magnetic stimulation of motor cortex in patients with Parkinson's disease: Preliminary results. Mov. Disord. 2007 22 : 1046 1050.
11. Pogarell O, Koch W, Pöpperl G et al. Acute prefrontal rTMS increases striatal dopamine to a similar degree as D-amphetamine. Psychiatry Res. 2007 156 : 251 255.
12. Machii K, Cohen D, Ramos-Estebanez C, Pascual-Leone A. Safety of rTMS to non-motor cortical areas in healthy participants and patients. Clin. Neurophysiol. 2006 117 : 455 471.
13. Wassermann EM. Risk and safety of repetitive transcranial magnetic stimulation: Report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr. Clin. Neurophysiol. 1998 108 : 1 16.
14. Belmaker B, Fitzgerald P, George MS et al. Managing the risks of repetitive transcranial stimulation. CNS Spectr. 2003 8 : 489.
15. Ebmeier KP, Donaghey C, Steele JD. Recent developments and current controversies in depression. Lancet 2006 367 : 153 167.
16. O'Reardon JP, Solvason HB, Janicak PG et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: A multisite randomized controlled trial. Biol. Psychiatry 2007 62 : 1208 1216.
17. Fregni F, Marcolin MA, Myczkowski M et al. Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation. Int. J. Neuropsychopharmacol. 2006 9 : 641 654.
18. Rossini D, Lucca A, Zanardi R, Magri L, Smeraldi E. Transcranial magnetic stimulation in treatment resistant depressed patients: A double-blind, placebo controlled trial. Psychiatry Res. 2005 137 : 1 10.
19. Rossini D, Magri L, Lucca A, Giordani S, Smeraldi E, Zanardi R. Does rTMS hasten the response to escitalopram, sertraline, or venlafaxine in patients with major depressive disorder? A double-blind, randomized, sham-controlled trial. J. Clin. Psychiatry 2005 66 : 1569 1575.
20. Rumi DO, Gattaz WF, Rigonatti SP et al. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: A double-blind placebo-controlled study. Biol. Psychiatry 2005 57 : 162 166.
21. Zanardi R, Magri L, Rossini D et al. Role of serotonergic genes polymorphism on response to transcranial magnetic stimulation in depression. Eur. Neuropsychopharmacol. 2007 17 : 651 657.
22. Gross M, Nakamura L, Pascual-Leone A, Fregni F. Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs. the earlier rTMS studies. Acta Psychiatr. Scand. 2007 116 : 165 173.
23. Iyer MB, Schleper N, Wassermann EM. Priming stimulation enhances the depressant effect of low-frequency repetitive transcranial magnetic stimulation. J. Neurosci. 2003 23 : 10867 10872.
24. Siebner HR, Lang N, Rizzo V et al. Preconditioning of low-frequency repetitive transcranial magnetic stimulation with transcranial direct current stimulation: Evidence for homeostatic plasticity in the human motor cortex. J. Neurosci. 2004 24 : 3379 3385.
25. Huang YZ, Edwards MJ, Rounis E, Bhatia KP, Rothwell JC. Theta burst stimulation of the human motor cortex. Neuron 2005 45 : 201 206.
26. Li X, Nahas Z, Anderson B, Kozel FA, Gorge MS. Can left prefrontal rTMS be used as a maintenance treatment for bipolar depression?. Depress. Anxiety 2004 20 : 98 100.
27. Benadhira R, Saba G, Samaan A et al. Transcranial magnetic stimulation for refractory depression. Am. J. Psychiatry 2005 162 : 193.
28. O'Reardon JP, Blumner KH, Peshek AD, Pradilla RR, Pimiento PC. Long-term maintenance therapy for major depressive disorder with rTMS. J. Clin. Psychiatry 2005 66 : 1524 1528.
29. Burt T, Lisanby SH, Sackeim HA. Neuropsychiatric applications of transcranial magnetic stimulation: A meta analysis. Int. J. Neuropsychopharmacol. 2001 5 : 73 103.
30. Herrmann LL, Ebmeier KP. Factors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression: A review. J. Clin. Psychiatry 2006 67 : 1870 1876.
31. Takahashi JS. Finding new clock components: Past and future. J. Biol. Rhythms 2004 19 : 339 347.
32. Bunney WE, Bunney BG. Molecular clock genes in man and lower animals: Possible implications for circadian abnormalities in depression. Neuropsychopharmacology 2000 22 : 335 345.
33. Benedetti F, Serretti A, Colombo C et al. Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2003 123 : 23 26.
34. Perlis ML, Giles DE, Buysse DJ, Tu X, Kupfer DJ. Self-reported sleep disturbance as a prodromal symptom in recurrent depression. J. Affect. Disord. 1997 42 : 209 212.
35. Wirz-Justice A, van den Hoofdakker RH. Sleep deprivation in depression: What do we know, where do we go? Biol. Psychiatry 1999 46 : 445 453.
36. Pflug B. The effect of sleep deprivation on depressed patients. Acta Psychiatr. Scand. 1976 53 : 148 158.
37. Barbini B, Colombo C, Benedetti F, Campori E, Bellodi L, Smeraldi E. The unipolar-bipolar dichotomy and the response to sleep deprivation. Psychiatry Res. 1998 79 : 43 50.
38. Wirz-Justice A, Benedetti F, Berger M et al. Chronotherapeutics (light and wake therapy) in affective disorders. Psychol. Med. 2005 35 : 939 944.
39. Colombo C, Lucca A, Benedetti F, Barbini B, Campori E, Smeraldi E. Total sleep deprivation combined with lithium and light therapy in the treatment of bipolar depression: Replication of main effects and interaction. Psychiatry Res. 2000 95 : 43 53.
40. Benedetti F, Barbini B, Fulgosi MC et al. Combined total sleep deprivation and light therapy in the treatment of drug-resistant bipolar depression: Acute response and long-term remission rates. J. Clin. Psychiatry 2005 66 : 1535 1540.
41. Wehr TA, Wirz-Justice A, Goodwin FK, Duncan W, Gillin JC. Phase advance of the circadian sleep-wake cycle as an antidepressant. Science 1979 206 : 710 713.
42. Berger M, Vollman J, Hohagen F et al. Sleep deprivation combined with consecutive sleep phase advance as a fast-acting therapy in depression: An open pilot trial in medicated and unmedicated patients. Am. J. Psychiatry 1997 154 : 870 872.
43. Wehr TA, Turner EH, Shimada JM, Lowe CH, Barker C, Leibenluft E. Treatment of rapidly cycling bipolar patient by using extended bed rest and darkness to stabilize the timing and duration of sleep. Biol. Psychiatry 1998 43 : 822 828.
44. Barbini B, Benedetti F, Colombo C et al. Dark therapy for mania: A pilot study. Bipolar Disord. 2005 7 : 98 101.
45. Barbini B, Bertelli S, Colombo C, Smeraldi E. Sleep loss as a possible factor in augmenting manic episode. Psychiatry Res. 1996 65 : 121 125.
46. Winkler D, Pjrek E, Iwaki R, Kasper S. Treatment of seasonal affective disorder. Expert Rev. Neurother. 2006 6 : 1039 1048.
47. Terman M, Terman J S. Light therapy for seasonal and non seasonal depression: Efficacy, protocol, safety and side effects. CNS Spectr. 2005 10 : 647 663.
48. Wirz-Justice A, Terman M, Oren DA et al. Brightening depression. Science 2004 303 : 467 469.
49. Terman M. Internal night. Arch. Gen. Psychiatry 2001 58 : 1115 1116.
50. Terman M, Terman JS. Light therapy. In : Kryger MH, Roth T, Dement WC (eds). Principles and Practice of Sleep Medicine, 4th edn. Elsevier, Philadelphia, PA, 2005 1424 1442.
51. Terman M. Evolving applications of light therapy. Sleep Med. Rev. 2007 11 : 423 427.
52. Modrego PJ, Fayed N, Pina MA. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy. Am. J. Psychiatry 2005 162 : 667 675.
53. Sastre-Garriga J, Ingle GT, Chard DT et al. Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis. Arch. Neurol. 2005 62 : 569 573.
54. Sanacora G, Gueorguieva R, Epperson CN et al. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch. Gen. Psychiatry 2004 61 : 705 713.
55. Rosenberg DR, Macmaster FP, Mirza Y et al. Reduced anterior cingulate glutamate in pediatric major depression: A magnetic resonance spectroscopy study. Biol. Psychiatry 2005 58 : 700 704.
56. Phillips ML, Travis MJ, Fagiolini A, Kupfer DJ. Medication effects in neuroimaging studies of bipolar disorder. Am. J. Psychiatry 2008 65 : 313 320.
57. Silverstone PH, McGrath BM, Kim H. Bipolar disorder and myo-inositol: A review of the magnetic resonance spectroscopy findings. Bipolar Disord. 2005 7 : 1 10.
58. Taylor M, Murphy SE, Selvaraj S et al. Differential effects of citalopram and reboxetine on cortical Glx measured with proton MR spectroscopy. J. Psychopharmacol. 2008 22 : 473 476.
59. Bernasconi A, Calabrese G, Benedetti F et al. Changes in brain glutamate correlate with antidepressant response to total sleep deprivation: A 3T 1H-MRS study. ECNP Workshop on Neuropsychopharmacology for young scientists in Europe. Nice, France, March 9-12. Eur. Neuropsychopharmacol. 2006 16 : S69.
60. Elliott R, Rubinsztein JS, Sahakian BJ, Dolan RJ. The neural basis of mood-congruent processing biases in depression. Arch. Gen. Psychiatry 2002 59 : 597 604.
61. Allen PP, Cleare AJ, Lee F et al. Effect of acute tryptophan depletion on pre-frontal engagement. Psychopharmacology (Berl) 2006 187 : 486 497.
62. Roiser JP, Levy J, Fromm SJ, Wang H, Hasler G, Sahakian BJ, Drevets WC. The effect of acute tryptophan depletion on the neural correlates of emotional processing in healthy volunteers. Neuropsychopharmacol. 2008 33 : 1992 2006.
63. Drevets WC. Functional neuroimaging studies of depression: The anatomy of melancholia. Annu. Rev. Med. 1998 49 : 341 361.
64. Drevets WC. Neuroimaging studies of mood disorders. Biol. Psychiatry 2000 48 : 813 829.
65. Davidson RJ, Pizzagalli D, Nitschke JB, Putnam KM. Depression: Perspectives from affective neuroscience. Annu. Rev. Psychol. 2002 53 : 545 574.
66. Drevets WC. Neuroimaging and neuropathological studies of depression: Implications for the cognitive-emotional features of mood disorders. Curr. Opin. Neurobiol. 2001 11 : 240 249.
67. Mayberg HS, Liotti M, Brannan SK et al. Reciprocal limbic-cortical function and negative mood: Converging PET findings in depression and normal sadness. Am. J. Psychiatry 1999 156 : 675 682.
68. Mayberg HS, Brannan SK, Mahurin RK et al. Cingulate function in depression: A potential predictor of treatment response. Neuroreport 1997 8 : 1057 1061.
69. Davidson RJ, Irwin W, Anderle MJ, Kalin NH. The neural substrates of affective processing in depressed patients treated with venlafaxine. Am. J. Psychiatry 2003 160 : 64 75.
70. Robertson B, Wang L, Diaz MT et al. Effect of bupropion extended release on negative emotion processing in major depressive disorder: A pilot functional magnetic resonance imaging study. J. Clin. Psychiatry 2007 68 : 261 267.
71. Fu CH, Williams SC, Cleare AJ et al. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: A prospective, event-related functional magnetic resonance imaging study. Arch. Gen. Psychiatry 2004 61 : 877 889.
72. Chen CH, Ridler K, Suckling J et al. Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biol. Psychiatry 2007 62 : 407 414.
73. Siegle GJ, Carter CS, Thase ME. Use of FMRI to predict recovery from unipolar depression with cognitive behavior therapy. Am. J. Psychiatry 2006 163 : 735 738.
74. Ebert D, Feistel H, Barocka A. Effects of sleep deprivation on the limbic system and the frontal lobes in affective disorders: A study with Tc-99m-HMPAO SPECT. Psychiatry Res. 1991 40 : 247 251.
75. Volk SA, Kaendler SH, Hertel A et al. Can response to partial sleep deprivation in depressed patients be predicted by regional changes of cerebral blood flow? Psychiatry Res. 1997 75 : 67 74.
76. Wu J, Buchsbaum MS, Gillin JC et al. Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am. J. Psychiatry 1999 156 : 1149 1158.
77. Holthoff VA, Beuthien-Baumann B, Pietrzyk U et al. Changes in regional cerebral perfusion in depression. SPECT monitoring of response to treatment. Nervenarzt 1999 70 : 620 626.
78. Langguth B, Wiegand R, Kharraz A et al. Pre-treatment anterior cingulate activity as a predictor of antidepressant response to repetitive transcranial magnetic stimulation (rTMS). Neuro Endocrinol. Lett. 2007 28 : 633 638.
79. Shinsuke K, Kenichi F, Yoshihiko K. Changes in regional blood flow after repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex in treatment-resistant depression. J. Neuropsychiatry Clin. Neurosci. 2008 20 : 74 80.
80. Hariri AR, Mattay VS, Tessitore A et al. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002 297 : 400 403.
81. Caspi A, Sugden K, Moffitt TE et al. Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 2003 301 : 386 389.
82. van de Ven VG, Formisano E, Röder CH et al. The spatiotemporal pattern of auditory cortical responses during verbal hallucinations. Neuroimage 2005 27 : 644 655.
83. Pezawas L, Meyer-Lindenberg A, Drabant EM et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: A genetic susceptibility mechanism for depression. Nat. Neurosci. 2005 8 : 828 834.
84. Pezawas L, Verchinski BA, Mattay VS et al. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J. Neurosci. 2004 24 : 10099 10102.
85. Schumacher J, Jamra R, Becker T et al. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol. Psychiatry 2005 58 : 307 314.
86. Benedetti F, Bernasconi A, Blasi V et al. Neural and genetic correlates of antidepressant response to sleep deprivation: A functional magnetic resonance imaging study of moral valence decision in bipolar depression. Arch. Gen. Psychiatry 2007 64 : 179 187.
87. Serretti A, Benedetti F, Zanardi R, Smeraldi E. The influence of serotonin transporter promoter polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005 29 : 1074 1084.
88. Hariri AR, Drabant EM, Munoz KE et al. A susceptibility gene for affective disorders and the response of the human amygdala. Arch. Gen. Psychiatry 2005 62 : 146 152.